Jarrow to Launch Probis Lp299v in U.S.
December 15, 2009
LOS ANGELESJarrow Formulas will launch Probis dietary supplement Lp299v for gut health in the U.S. Health Food channel. Probis partner Institut Rosell awarded nutritional supplement company Jarrow Formulas exclusive rights to sell a dietary supplement based on Probis bacteria, Lp299v in the Health Food channel in the United States. The product will be launched in the first quarter of 2010.
The agreement with Jarrow Formulas is another important step in our company's strategy to make Lp299v available on a global scale, says Michael Oredsson, CEO at Probi. The United States is an important and growing market for probiotic dietary supplements. We are very pleased to launch Lp299v in the U.S. health food channel. Jarrow Formulas is one of the leading players in the probiotic category. Jarrows mission is to promote optimal health with high quality, effective, affordable and cutting edge formulations, which are based on sound scientific research. This philosophy is in line with the high quality of Lp299v.
You May Also Like